These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19579161)

  • 21. Biopharmaceuticals: recent approvals and likely directions.
    Walsh G
    Trends Biotechnol; 2005 Nov; 23(11):553-8. PubMed ID: 16051388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in targeted therapeutic agents.
    Nicolaides NC; Sass PM; Grasso L
    Expert Opin Drug Discov; 2010 Nov; 5(11):1123-40. PubMed ID: 22827748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abstracts from the 11th North American International Society for the Study of Xenobiotics (ISSX) Meeting. 27-31 October 2002, Orlando, Florida, USA.
    Drug Metab Rev; 2002; 34 Suppl 1():1-232. PubMed ID: 12418476
    [No Abstract]   [Full Text] [Related]  

  • 24. ICH discussion on pharmacokinetics and toxicokinetics and contributors.
    Ohno Y
    Drug Metab Pharmacokinet; 2013; 28(5):379-82. PubMed ID: 24162438
    [No Abstract]   [Full Text] [Related]  

  • 25. MicroRNAs as key regulators of xenobiotic biotransformation and drug response.
    Bolleyn J; De Kock J; Rodrigues RM; Vinken M; Rogiers V; Vanhaecke T
    Arch Toxicol; 2015 Sep; 89(9):1523-41. PubMed ID: 25079447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning more about checkpoint blockades.
    Cancer Discov; 2014 Aug; 4(8):OF5. PubMed ID: 25092760
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibody-mediated side effects of recombinant proteins.
    Frost H
    Toxicology; 2005 Apr; 209(2):155-60. PubMed ID: 15767028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [RNA as pharmaceuticals].
    Takano-Ohmuro H
    Tanpakushitsu Kakusan Koso; 2006 Dec; 51(16 Suppl):2528-35. PubMed ID: 17471974
    [No Abstract]   [Full Text] [Related]  

  • 29. The biochemistry of drug metabolism--an introduction: part 1. Principles and overview.
    Testa B; Krämer SD
    Chem Biodivers; 2006 Oct; 3(10):1053-101. PubMed ID: 17193224
    [No Abstract]   [Full Text] [Related]  

  • 30. Liquid chromatography-mass spectrometry in the study of the metabolism of drugs and other xenobiotics.
    Oliveira EJ; Watson DG
    Biomed Chromatogr; 2000 Oct; 14(6):351-72. PubMed ID: 11002274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Genetic significance of determined oxidation of drugs and xenobiotics in the pathogenesis of neoplastic diseases].
    Niewiński P; Orzechowska-Juzwenko K
    Pol Merkur Lekarski; 1997 Jan; 2(7):71-5. PubMed ID: 9296908
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal UDP-glucuronosyltransferases and the glucuronidation of xenobiotics and endogenous mediators.
    Knights KM; Miners JO
    Drug Metab Rev; 2010 Feb; 42(1):63-73. PubMed ID: 19780654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human cytochrome P450 monooxygenases for drug metabolite synthesis.
    Schroer K; Kittelmann M; Lütz S
    Biotechnol Bioeng; 2010 Aug; 106(5):699-706. PubMed ID: 20506361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs and human memory (part 2). Clinical, theoretical, and methodologic issues.
    Ghoneim MM
    Anesthesiology; 2004 May; 100(5):1277-97. PubMed ID: 15114228
    [No Abstract]   [Full Text] [Related]  

  • 35. [What do we know about the drug metabolism?].
    Pelkonen O; Raunio H
    Duodecim; 1998; 114(10):971-7. PubMed ID: 11524785
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic monoclonal antibodies in clinical neurology].
    Buttmann M; Wiendl H
    Nervenarzt; 2010 Jun; 81(6):753-64; quiz 765-6. PubMed ID: 20232033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolomics in toxicology: preclinical and clinical applications.
    Robertson DG; Watkins PB; Reily MD
    Toxicol Sci; 2011 Mar; 120 Suppl 1():S146-70. PubMed ID: 21127352
    [No Abstract]   [Full Text] [Related]  

  • 38. Abstracts of the 9th International Society for the Study of Xenobiotics (ISSX) Meeting. September 4-8, 2010. Istanbul, Turkey.
    Drug Metab Rev; 2010 Aug; 42 Suppl 1():S1-323. PubMed ID: 20842800
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytochromes P450, drugs, and diseases.
    Guengerich FP
    Mol Interv; 2003 Jun; 3(4):194-204. PubMed ID: 14993447
    [No Abstract]   [Full Text] [Related]  

  • 40. Abstracts of the 17th North American Regional ISSX International Society for the Study of Xenobiotics) Meeting. October 16–20, 2011. Atlanta, Georgia, USA.
    Drug Metab Rev; 2011 Nov; 43 Suppl 2():1-230. PubMed ID: 22148146
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.